IN8bio, Inc. (INAB) — Financial statements
Income statement, balance sheet, and cash flow for IN8bio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 3 | 0.00↓100.0% | 3 | 0.00 | 0.00 | |
| Gross Profit | -3 | 0.00↑100.0% | -3 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 10↓39.8% | 17↑0.8% | 17↑19.7% | 14↑91.4% | 7 | |
| General & Administrative Expenses | 10↓23.6% | 13↓6.5% | 14↓6.6% | 14↑97.9% | 7 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 10↓23.6% | 13↓6.5% | 14↓6.6% | 14↑97.9% | 7 | |
| Other Expenses | -3↓398.4% | 0.84↑133.5% | -3 | 0.00 | 0.00 | |
| Operating Expenses | 17↓43.0% | 30↑9.3% | 28↓2.4% | 29↑94.6% | 15 | |
| Total Costs & Expenses | 20↓34.7% | 30↑0.3% | 30↑6.4% | 29↑94.6% | 15 | |
| Operating Results | ||||||
| Operating Income | -20↑34.7% | -30↓0.3% | -30↓6.4% | -29↓94.6% | -15 | |
| Depreciation & Amortization | 3↓5.8% | 3↑6.2% | 3↑126.7% | 1↑40.0% | 0.79 | |
| EBITDA | -17↑35.6% | -27↑2.0% | -28↓0.3% | -27↓97.7% | -14 | |
| EBIT | -20↑32.9% | -30↑1.4% | -30↓5.2% | -29↓94.6% | -15 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.42↑83.0% | 0.23 | 0.00 | 0.00 | 0.00 | |
| Interest Income | 0.42↑83.0% | 0.23 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -0.84↓153.9% | -0.33 | 0.00 | 0.00 | |
| Other Income / Expenses | 0.42 | 0.00↓100.0% | 0.33 | 0.00 | 0.00 | |
| Income Before Tax | -19↑36.1% | -30↓1.4% | -30↓5.2% | -29↓94.6% | -15 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -19↑36.1% | -30↓1.4% | -30↓5.2% | -29↓94.6% | -15 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -19↑36.1% | -30↓1.4% | -30↓5.2% | -29↓94.6% | -15 | |
| Bottom-Line Net Income | -19↑36.1% | -30↓1.4% | -30↓5.2% | -29↓94.6% | -15 | |
| EPS (Basic) | -4.44↓678.9% | -0.57↑43.0% | -1.00↑26.5% | -1.36↓74.4% | -0.78 | |
| EPS (Diluted) | -4.44↓678.9% | -0.57↑43.0% | -1.00↑26.5% | -1.36↓74.4% | -0.78 | |
| Weighted Average Shares | 4↓91.8% | 54↑79.3% | 30↑42.4% | 21↑11.6% | 19 | |
| Weighted Average Diluted Shares | 4↓91.8% | 54↑79.3% | 30↑42.4% | 21↑11.6% | 19 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.